Regulation of growth factor gene expression in degenerating motoneurons of the murine mutant wobbler: a cellular patch-sampling/RT-PCR study.
Motoneuronal degenerative diseases are characterized by their progressivity; once affected, the motoneurons remain in altered states during an intermediate phase of degeneration prior to their final disappearance. Whether this survival period coincides with active metabolic rearrangements in the affected neuron remains unknown. As a first step toward the elucidation of this question, we developed cDNA pooled samples obtained from degenerating and control motoneuron mRNA populations through cellular patch sampling and RT-PCR, using the murine wobbler mutant as a model of spinal atrophy. Hybridization of the cDNA pools to various markers of intact or degenerating motoneurons allowed us to verify the cellular specificity of the patch sampling and indicated conservation of the original mRNA population complexity. Exploration of transcriptional alterations of genes encoding growth factors thought to be involved in motoneuronal development revealed that gene expression of the neurotrophin BDNF was induced in affected motoneurons, while expression of neurotrophin-3 was present in both neuronal types. Likewise, expression of a member of the epidermal growth factor (EGF) family, the neuregulin transcript sensory motor neuron-derived factor, was detected in both control and degenerating motoneurons, while transforming growth factor alpha, the functional homolog of EGF, was present only in the affected motoneurons. Immunohistochemical detection of corresponding proteins corroborated these observations. These results demonstrate that, during the course of their degeneration, motoneurons can initiate expression of novel genes which lead to the production of molecules endowed with trophic and/or differentiative properties for the neurons themselves and their glial environment. They also validate the use of the developed cDNA pooled samples for further exploration of transcriptional alterations taking place in degenerating motoneurons.
Junier
M P
MP
IM3, Fac Médecine, INSERM U421, 8 rue du Gal Sarrail, Créteil, 94010, France. junier@im3.inserm.fr
Legendre
P
P
Esguerra
C V
CV
Tinel
M
M
Coulpier
M
M
Dreyfus
P A
PA
Bähr
M
M
D000818:Animals; D005786:Gene Expression Regulation / Q000502:physiology*; D006133:Growth Substances / Q000235:genetics*; D066298:In Vitro Techniques; D051379:Mice; D008818:Mice, Neurologic Mutants; D009046:Motor Neurons / Q000378:metabolism / Q000502:physiology*; D009410:Nerve Degeneration / Q000503:physiopathology*; D009414:Nerve Growth Factors / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
D006133:Growth Substances; D009414:Nerve Growth Factors